antibiotic research, antibiotic resistance, antimicrobial resistance, multidrug resistance, superbugs
0 Comment
Registration Opens for 21st Superbugs & Superdrugs 2019
antibiotic resistance, antimicrobial resistance, immunotherapy, infectious diseases, superbugs
0 Comment
21st Annual Superbugs & Superdrugs Conference
drug development, orphan drugs, patient centricity, patient organisations, Rare diseases
0 Comment
Attendees Released for Orphan Drugs & Rare Diseases
cancer, immuno-oncology, immunotherapy, MHRA, microbiome
0 Comment
Just Over 1 Week Until Immuno-Oncology 2018 Commences
HTA, market access, orphan drugs, pharmaceutical conference, rare disease
0 Comment
Pharma Giants Unite to Improve Rare Disease Treatment
cancer, car t-cell, combination therapy, immuno-oncology, immuno-therapy
0 Comment
MHRA, Pfizer & Autolus Sign Up for Immuno-Oncology 2018
clinical trials, orphan drugs, patient centricity, patients, Rare diseases
0 Comment
Chair Invitation to Orphan Drugs & Rare Diseases 2018
cancer conference, Cancer Therapy, checkpoint inhibitors, immuno-oncology, immuno-therapy
0 Comment
Less than 4 Weeks until Immuno-Oncology Conference
biotech industry, orphan drugs, pharmaceutical conference, Rare diseases, treatment
0 Comment
Orphan Drugs and Rare Diseases Conference – London
